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ABSTRACT
The purpose of this thesis is to analyze gene expression in grapevine under different
treatments using a mixed linear statistical model. The experiment involves two Vitis
species (V. vinifera Cabernet sauvignon and V. aestivalis Norton) and applies two
different treatments to them (inoculation with Erysiphe necator conidiospores and mock
inoculation). There are three biological replicates measured at each of the following six
assigned time points: 0, 4, 8, 12, 24, and 48 hours. By setting up split-plot model for the
data, statistical hypotheses concerning gene expressions, especially gene expressions in
terms of treatment effect, are tested. The result of the analysis identify those genes
expressed differently, and further experiments will indicate biological properties of those
specific genes. After performing the analysis by using the split-plot model, discussions
about another possible model, repeated measures design, is introduced at the end of this
thesis in order to incorporate the potential biological property, such as diurnal pattern,
into the modeling and analysis. By these series of analysis, certain genes are found with
different expression, such as the gene with ID 000002 and ID 000004. This result will be
useful in further biological researches.
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CHAPTER 1: INTRODUCTION

Understanding how the genome of an organism function is primary focus of
modern biology research. The high cost of generating functional genomics data requires
researchers to use experimental material as efficiently as possible, and expectations are
that the data are analyzed with great precision. Usually, genomic studies involve a large
number of observations, and the downstream analysis and interpretation of the resulting
vast datasets is challenging. In order to gather information from data, substantial biology
knowledge and statistical technique have to be applied in combination.
Functional genomics is a powerful tool to improve the health and productivity of
agricultural plants. Researchers conducted an experiment involving two Vitis species, two
treatments, and made three measurements at each of six assigned time points. This
experiment involves the following:
1. Two Vitis species: V. vinifera Cabernet sauvignon (CS) and V. aestivalis
Norton (N);
2. Two treatments applied to each species: inoculation with E. necator
conidiospores (INC) and mock inoculation (MOC);
3. Observations at six time points for each species under each treatment: 0 hour,
4 hours, 8 hours, 12 hours, 24 hours, 48 hours;
4. Three biological replicates are made at each time point for each species under
each treatment.
The main purpose of this experiment is to monitor the expression levels of 16436
Vitis genes across the two treatments. Statistical methods are applied to analyze the signal
levels of each of these 16436 genes to assess the significance of the differences between
these two treatments. The ultimate goal is to differentiate those genes that express at
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significantly different level the treatments. In this procedure, we have to set up an
appropriate statistical model from the data observed in experiment. Statistical hypothesis
testing will be used, as well. For this certain experiment, we will use split-plot
experiment design to model the data researchers got from experiment. In Chapter 2, we
will use observations of one gene to explain how split-plot experiment design works and
define related concepts, such as whole-plot and split-plot, and then we will interpret what
the general split-plot model looks like. The split-plot model will be applied to all genes’
observations to analyze gene expressions in Chapter 3. Chapter 4 will discuss whether
there are other experiment design models which would be more appropriate to be applied,
such as repeated measurement (experiment design) model, which will be discussed later
in this thesis. And finally, Chapter 5 will contain a summary of all results and
conclusions got from previous chapters.
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CHAPTER 2: SPLIT-PLOT DESIGN

Split-plot designs are extremely popular in experimental design since they cover a
common case in real world, which is when you have a factor that you want to study but
cannot change as often as your other factors. In a factorial experimental arrangement,
however, it is not always possible or practical to completely randomize the order of
experiment and to obtain genuine independent replicates. These practical conditions or
restrictions lead to a split-plot design. The following data are the signal values of a gene
(called GENE00001) in the grapevine study which will be used to explain split-plot
model.

Section 2.1 Example
Let us use the single stage Split-plot design as an example; models for multiple
stages cases are derived similarly.
Consider observations of first gene (with ID GENE00001). We select the first
replicates only at each time point as an example here to explain how the split-plot model
work. Recall that we have two species, Cabernet sauvignon (CS) and Norton (N); two
treatments, Inoculation with Erysiphe - necator conidiospores (INO) and mock
inoculation (MOC); and that there are six assigned time points (0, 4, 8, 12, 24, 48 hours)
for each species and each treatment.
Table 2.1.1 shows the sample data. It is clear that the four combinations of species
and treatments, CS and INO, CS and MOC, N and INO, N and MOC, make four small
groups or blocks. This gives a general randomized block structure. Six time points divide
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each small group into six subgroups. These three factors, SPECIES, TREATMENT, and
TIME are fixed factors. By viewing Table 2.1.1, you might think of this experiment as a
2×2×6 factorial design with one replication per cell. However, in a completely
randomized factorial experiment, researchers would have to grow, for instance, 60
Cabernet sauvignon (CS) plants and apply Inoculation with E. necator conidiospores
(INO). After the inoculation, they need to randomly select a time point from the hours 0,
4, 8, 12, 24, and 48, say 8, and then at the 8-hour time point, they need to harvest 10
leaves, one from each plant, to make one GeneChip in order to obtain observations.
Similar procedures have to be done six times, to get all the six observations. Of course,
this is not possible or practically not feasible! We would argue that other ways of
carrying out the randomization is too expensive.

Table 2.1.1: Observations of GENE00001 (with First Replicate Signals Only)
Species Treatment Time Observation Species Treatment Time Observation
CS
INO
0
2416.7
N
INO
0
2711.2
CS
INO
4
2519.7
N
INO
4
2745.4
CS
INO
8
2704
N
INO
8
2769.7
CS
INO
12
2434.6
N
INO
12
2347.3
CS
INO
24
2834
N
INO
24
2439.2
CS
INO
48
2680
N
INO
48
2662.2
CS
MOC
0
2819.2
N
MOC
0
2507.6
CS
MOC
4
3151.8
N
MOC
4
2587.9
CS
MOC
8
2262.5
N
MOC
8
2255.9
CS
MOC
12
2254.5
N
MOC
12
2453.9
CS
MOC
24
3105.1
N
MOC
24
2476.5
CS
MOC
48
3019.2
N
MOC
48
2678.3
What really happened is the experiment was done in a split-plot design setting.
After the inoculation, experimenters randomly select 10 plants to produce the first
GeneChip at time 0 (hour), at time 4 (4 hours later) randomly select another set of 10
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plants to produce the second GeneChip, and so on. The entire experiment was replicated
for other three treatment combinations (CS and MOC, N and INO, and N and MOC).
These four treatment combinations are the whole plots, and time points (0, 4, 8, 12, 24,
and 48) are the split-plots. The effects of the whole plot are confounded with the replicate
effects.
Apart from those we discussed above, we might think that time effects are nested
within each species and treatment combination, but actually they are not since each time
point crossed with all species and treatment combinations.
Taking all effects into consideration, the split-plot model for this experiment is:
Model 1: Yijk = µ + αi + θj + (αθ)ij + βk+ (αβ)ik + (θβ)jk + (αθβ)ijk + εijk
Where
µ is the grand mean;
αi is the species effect for the ith species;
θj is the treatment for the jth treatment;
(αθ)ij is the interaction effect between the ith species and the jth treatment;
βk is the time effect for the kth time point;
(αβ)ik is the interaction effect for the ith species at the kth time point;
(θβ)jk is the interaction effect for the jth treatment at the kth time point;
(αθβ)ijk is the interaction effect for the ith species with the jth treatment applied at the kth
time point;
εijk is the random error term.
With those assumptions listed above, we can start to derive Sum of Squares and
prepare for ANOVA table to do further analysis. For i = 1, 2; j = 1, 2; k = 1, 2. yijk is
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observations. y… is defined as overall mean. yi.. ,y.j. , y..k represent mean of all
observations of ith species, mean of all observations of jth treatment, and mean of all
observations of kth time points, respectively. yij. ,yi.k , y.jk are mean of all observations of
ith species applied with jth treatment, mean of all observations of ith species at kth time
points and mean of all observations of jth treatment at kth time points, respectively.
Assumptions are involved. θj ̴ N(0, σθ2), (αθ)ij ̴ N(0, σαθ2), (θβ)jk ̴ N(0,
σθβ2), (αθβ)ijk ̴ N(0, σαθβ2), εijk ̴ N(0, σε2) and they are mutually independent for i =
1, 2; j = 1, 2; k = 1, 2,…, 6.
2

6

2

∑ ∑ ∑(yijk − y… )2
i=1 j=1 k=1
m

2

= 2 × 6 ∑(yi.. − y…

)2

j=1

6

2

k=1

)2

2

+ 2 × 6 ∑(y.j. − y… ) + 6 ∑ ∑(yij. − yi.. − y.j. + y… )

i=1

+2 × 2 ∑(y..k − y…

2
2

i=1 j=1

6

+ 2 ∑ ∑(yi.k − yi.. − y..k + y… )2
i=1 k=1

6

2

+2 ∑ ∑(y.jk − y.j. − y..k + y… )2
j=1 k=1
2

2

6

+ ∑ ∑ ∑(yijk − yij. − yi.k − y.jk + yi.. + y.j. + y..k + y… )

2

i=1 j=1 k=1

That is, SSTotal = SSSpecies + SSTreatment + SSSpecies×Treatment + SSTime+ SSSpecies×Time +
SSTreatment×Time + SSSpecies×Treatment×Time. Specifically, we can get these results:
SSTotal = ∑2𝑖=1 ∑2𝑗=1 ∑6𝑘=1(𝑦𝑖𝑗𝑘 − 𝑦… )2; d.f. = 2×2×6 - 1
SSSpecies = 2 × 6 ∑2𝑖=1(𝑦𝑖.. − 𝑦… )2; d.f. = 2-1
SSTreatment = 2 × 6 ∑2𝑗=1(𝑦.𝑗. − 𝑦… )2 ; d.f. = 2-1
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2

SSSpecies×Treatment = 6∑2𝑖=1 ∑2𝑗=1(𝑦𝑖𝑗. − 𝑦𝑖.. − 𝑦.𝑗. + 𝑦… )2 ; d.f. = (2-1) (2-1)
SSTime = 2 × 2 ∑6𝑘=1(𝑦..𝑘 − 𝑦… )2 ; d.f. = 6-1
SSSpecies×Time = 2∑2𝑖=1 ∑6𝑘=1(𝑦𝑖.𝑘 − 𝑦𝑖.. − 𝑦..𝑘 + 𝑦… )2 ; d.f. = (2-1) (6-1)
SSTreatment×Time = 2∑2𝑗=1 ∑6𝑘=1(𝑦.𝑗𝑘 − 𝑦.𝑗. − 𝑦..𝑘 + 𝑦… )2 ; d.f. = (2-1) (6-1)
SSSpecies×Treatment×Time = ∑2𝑖=1 ∑2𝑗=1 ∑6𝑘=1(𝑦𝑖𝑗𝑘 − 𝑦𝑖𝑗. − 𝑦𝑖.𝑘 − 𝑦.𝑗𝑘 + 𝑦𝑖.. + 𝑦.𝑗. + 𝑦..𝑘 + 𝑦… )2 ;
d.f. = (2-1) (2-1) (6-1)
On the procedure of deriving, we cannot find any expression to estimate the sum
of square of our error term εijk; in other words, the error term in the model above is not
estimable. Split-plot design has both whole plots and split-plots, which leads to multiple
error term for different plot levels. In terms of this, when doing analysis and hypothesis
testing, we should figure out which term to use as error term.
Since we define SPECIES and TREATMENT as whole-plot factors, we can
consider the interaction effect of SPECIES and TREATMENT as the error term within
whole-plot level. We consider the interaction between treatment and species to be a
random effect since the interaction effect is different for each species and each treatment.
We can only control the treatment and the species, but we cannot control or predict the
effect of this interaction. Applying similar logic to split-plot level, interaction effect of
SPECIES, TREATMENT and TIME will be a possible error term to use in doing
analysis. In fact, there exists statistical reason to doing this prediction. How to determine
these error is shown in Table 2.1.2. Details of each term in the EMS column will be
discussed in Appendix II. Table 2.1.2 classifies all factors into whole-plot factors and
split-plot factors and gives degree of freedom directly, which is convenient. We have
another thing to do before analysis, which is, normalizing data. Due to all normal
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assumptions we made above for our model, we have to check if our data is (approximate)
normally distributed, or not. For raw data listed in Table 2.1.1, we can get histogram as
what shows in Figure 2.1.

Table2.1.2: EMS (Error of Mean Squares) of model for GENE00001 sample (with first
replicates only)
2
2
6
F

R

F

Sources d.f.

i

j

k

EMS

αi

2-1

0

2

6

σε2 + 6σαθ2 + 2×6

θj

2-1

2

1

6

σε2 + 2×6

6

σε2 +

0

𝑗
𝑗𝑘
σε2 + 2 𝜎𝛼𝜃𝛽 2 + 2 (2−1)(6−1)

Whole
plot

(αθ)ij

(2-1)(2-1)

0

1

6σαθ

∑𝑖 𝛼𝑖 2
2−1

∑𝑗 𝜃𝑗 2
2−1
2

∑ ∑𝑘(𝜃𝛽) 2

βk

6-1

0

2

+ 2×2
Split
plot

∑𝑘 𝛽𝑘 2
6−1

∑𝑖 ∑𝑗(𝛼𝛽)𝑖𝑗 2

(αβ)ik

(2-1)(6-1)

0

2

0

σε2 + 2 𝜎𝛼𝜃𝛽 2 + 2

(θβ)jk

(2-1)(6-1)

0

1

0

σε2 + 2 𝜎𝛼𝜃𝛽 2

(αθβ)ijk

(2-1)(2-1)(6-1)

0

1

0

σε2 + 𝜎𝛼𝜃𝛽 2

1

1

1

σε2 (not estimable)

εijk
Total

(2−1)(6−1)

2×2×6-1

The raw data of this sample is approximately bell-shaped (referring to Figure 2.1),
except that the data range from 2000 to 3400. The magnitude of raw data is too large,
which increases noise effects. Normalization is necessary here. Usually, two method will
be used. One is making log-transformation. Log-transformation decrease the magnitude
of the data. The other is finding z-scores for each of the observations. Z-scores
calculation forces data to be normally distributed. This approach usually is used when the
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histogram of data is not close to bell-shaped at all. For our sample data, the original
histogram is already close to the histogram of normal distribution, so log-transformation
should be enough. The basic idea is transform our raw data into log 2 (raw data + 1). The
reason for adding 1 is to avoid the case when some observations are zeros. After doing
this, we will get the data and its histogram as shown in Table 2.1.3.

0.0015

0.0010

0.0005

0.0000
2100

2300

2500

2700

2900

3100

3300

Observation

Figure 2.1 Histogram for raw data of GENE00001 (first replicate only)
Notice that this histogram in Figure 2.2 has two peaks, which is different from the
unimodal normal distribution. For most experiment, this is acceptable. We can use
Normal QQ-plot to support our statement. In Figure 2.3, we notice all points are
extremely close to the straight line. Once the line made by points is approximately a
straight line, we claim that the data is approximately normal, which is totally enough for
experimental modeling.
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3.0

2.5

2.0

1.5

1.0

0.5

0.0
11.1

11.2

11.3

11.4

11.5

11.6

11.7

trans-obs.

Figure 2.2 Histogram for transformed data of GENE00001 (first replicate only)
Table 2.1.3: Transformed Observations of GENE00001 sample (with first replicate
signals only)
Species Treatment Time Observation Specie Treatment Time Observation
CS
INO
0
11.2394
N
INO
0
11.4052
CS
INO
4
11.2996
N
INO
4
11.4233
CS
INO
8
11.4014
N
INO
8
11.4360
CS
INO
12
11.2500
N
INO
12
11.1974
CS
INO
24
11.4691
N
INO
24
11.2527
CS
INO
48
11.3885
N
INO
48
11.3789
CS
MOC
0
11.4615
N
MOC
0
11.2926
CS
MOC
4
11.6224
N
MOC
4
11.3381
CS
MOC
8
11.1443
N
MOC
8
11.1401
CS
MOC
12
11.1392
N
MOC
12
11.2614
CS
MOC
24
11.6008
N
MOC
24
11.2746
CS
MOC
48
11.5604
N
MOC
48
11.3876
Now the data are ready for analysis. By using statistical software, we can get the
following ANOVA table (referring Table 2.1.4). We can read all results of sum of
squares we listed earlier in this chapter from the Sum of Square column, directly. Notice
that this ANOVA table is not classified by whole-plot factor and split-plot factor, so we
10

need to be really careful when determined error terms to apply. Recall from the
discussion above that, we consider interaction of SPECIES and TREATMENT as whole
plot error, and interaction among SPECIES, TREATMENT and TIME is the split-plot
error.
Therefore, MSE of whole-plot error is 0.03224905 and all whole-plot factors
should be tested with using this value. Similarly, MSE of split-plot error is 0.01101595,
and it is used to test split-plot factor. Of course, degree of freedoms should all be matched
to tests. For example, if we want test SPECIES factor with hypothesis statement as
𝐻0 : 𝛼𝑖 = 0 𝑣𝑠. 𝐻𝑎 : 𝛼𝑖 ≠ 0
0.02591636

The F-ratio should be 0.03224905 and the critical value read from F distribution table
should be with degree of freedom (1, 1). The results obviously show that SPECIES factor
is significant.
Checking effects factor by factor, it is clear that all term in our model are
significant, which implies that this model is fit for our sample data. Some useful index
can display this fitness well, residual, for example. If we can get an approximately
horizontal residual plot, we can claim that the model we set up for specific set of data is
fit well. Due to the original experiment design and the way we pick our sample data, the
residuals for this model is zeros, which is possible but rare in most cases.
Until now, we analyze our sample data precisely with a lot of details from
different aspects and get some knowledge about split-plot design by this specific case. All
those ideas and concerns can be applied to general split-plot case. Now, let us see the
general split-plot looks like.

11

11.6

trans.obs

11.5

11.4

11.3

11.2

11.1
-3

-2

-1

0

1

2

Normal Distribution

Figure 2.3 Normal QQ-plot of model for GENE00001 sample
Table 2.1.4 ANOVA table of Split-plot model for GENE00001 Sample
Sources
Degree of Sum of Squares
Mean Square
Freedom
(SS)
Error (MSE)
Species
1
0.0259164
0.02591636
Treatment

1

0.0002777

0.00027767

Time

5

0.1501550

0.03003100

Species×Treatment

1

0.0322491

0.03224905

Species×Time

5

0.0638854

0.01277709

Treatment×Time

5

0.1078854

0.02157709

Species×Treatment×Time 5

0.0550798

0.01101595
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Section 2.2 Split-plot Design
What is split-plot design? Split-plot experimental designs were originally
developed by Fisher (1966) for use of in agriculture experiments. Split-plot designs are
used when treatment factors can be categorized into two groups. Group A includes any
factors that are relatively stable during the experiment, and Group B contains other
relatively unstable factors. Formally speaking, Group A factors define whole-plot and
Group B factors creates split-plots. It is not hard to notice that split plots are nested
within whole plots. Usually, Split-plot design is nested within standard designs, such as
Completely Randomized Design (CRD), Randomized Block Design (RBD) and Latin
Square Design (LSD). This special structure makes Split-plot designs different from other
standard designs. Depending on the needs of experiment, whole plot can split up multiple
times to make multiple stages of split plots, for instance, Split-split-plot design. The
model of Split-plot designs depends on how many stages of split plots the experiment has
and which standard design it works with.
Continuing using those notation from our previous example, the general split-plot
model usually as following:
Model 1: Yijk = µ + αi + θj + (αθ)ij + βk+ (αβ)ik + (θβ)jk + (αθβ)ijk + εijk
if there were only two whole-plot factor and one split-plot factor as the case in our
example. Similarly, all these terms in the model is defined as: µ is the grand mean; αi is
the species effect for ith species; θj is the treatment for jth treatment; (αθ)ij is the
interaction effect between ith species and jth treatment applied; βk is the time effect for kth
time point; (αβ)ik is the interaction effect for ith species and kth time point; (θβ)jk is the
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interaction effect for jth treatment and kth time point ; (αθβ)ijk is the interaction effect
among ith species, jth treatment and kth time point ; and εijk is the random error term .
The assumptions are θj ̴ N(0, σθ2), (αθ)ij ̴ N(0, σαθ2), (θβ)jk ̴ N(0, σθβ2),
(αθβ)ijk ̴ N(0, σαθβ2), εijk ̴ N(0, σε2) and they are mutually independent for i = 1, 2, …, I; j
= 1, 2, …, J; k = 1, 2,…, K. General split plot model still follows the sum of squares rule:
SSTotal = SSSpecies + SSTreatment + SSSpecies×Treatment + SSTime+ SSSpecies×Time + SSTreatment×Time +
SSSpecies×Treatment×Time.
Generalizing what we have already gotten from specific example above, the formulas for
sum of squares can be calculated as
SSTotal = ∑Ii=1 ∑Jj=1 ∑Kk=1(yijk − y… )2;
SSSpecies = JK ∑Ii=1(yi.. − y… )2;
SSTreatment = IK ∑Jj=1(y.j. − y… )2 ;
SSSpecies×Treatment = K∑Ii=1 ∑Jj=1(yij. − yi.. − y.j. + y… )2;
SSTime = IJ ∑Kk=1(y..k − y… )2;
SSSpecies×Time = J∑Ii=1 ∑Kk=1(yi.k − yi.. − y..k + y… )2;
SSTreatment×Time = I∑Jj=1 ∑Kk=1(y.jk − y.j. − y..k + y… )2;
SSSpecies×Treatment×Time = ∑Ii=1 ∑Jj=1 ∑Kk=1(yijk − yij. − yi.k − y.jk + yi.. + y.j. + y..k + y… )2 ;
Sum of square of error term εijk is still not estimable, even for the general model.
There are many reasons leading to this kind of estimation problem, but the typical one is
that the error term has already been partitioned by other random effects in the model. In
terms of this concern, we need to modify the existing model to make it standard.
Expected Mean Squares (EMS) is an effective tool. Furthermore, for standard designs, all
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factor effects are treated as fixed effects. Here in Split-plot design, some factors are
random and they may be randomized in different stages. This randomization structure
leaves a challenge to data analysis and related testing. Especially in F-tests, we have to be
careful about the denominators since they may not be the MSE as what we have been
used in standard design. To determine the appropriate denominators, we need to know
how to write the EMS for all sources of variation.
The specific method and rules about how to calculate EMS column in Table 2.2.1
will be shown in Appendix II with i = 1, 2,…, I; j = 1, 2,…, J; k = 1, 2,…, K. This is a
serious disadvantage for full model as Model 1 above since Mean square error plays main
role in many kinds of testing. Combining with what we get from Table 2.2.1, σε2 + Kσαθ2
is treated as the EMS of whole-plot error and σε2 + σαθβ2 is taken as the EMS of split-plot
error.
Back to the Model 1 we set up, the interaction term (αθ) ik is often referred to as
the whole plot error representing by εwi(j) and εwi(j) ’s ̴ i.i.d.N(0, σW2).The usual
assumption is that this interaction does not exist, that this term is really an estimate of the
error within the whole plot. The term (αθβ)ijk is referred to as the split plot error
representing by εsk(ij) and εsk(ij)’s ̴ i.i.d. N(0, σS2).
Sometimes the (αβ)ik or (θβ)jk is also considered to be nonexistent depending on
experiment data, and is combined with (αθβ)ijk as a part of error term εijk (Hicks et al,
1999). It’s clear that there is a nested blocking structure: whole-plots are nested within
blocks and split plots are nested within whole plots. This structure leads to two kinds of
randomization. One source of randomization are the whole plots, the other is the split
plots.
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Table 2.2.1 EMS for Split-plot design based on GENE00001 sample
I
J
K
F
R
F
Sources d.f.
i
j
k
EMS
∑ 𝛼2
I-1
αi
0
J
K
σ 2 + Kσ 2 + JK 𝑖 𝑖
ε

Whole θj
plot

𝑚−1

J-1

I

1

K

σε2 + IKσθ2

(αθ)ij

(I-1)(J-1)

0

1

K

σε2 + Kσαθ2

βk

K-1

0

J

0

σε2 + σαθβ2 + Jσθβ2 + IJ

0

J

0

𝑖 𝑗
𝑖𝑗
σε2 + σαθβ2 + J (𝑚−1)(𝑏−1)

(αβ)ik
Split
plot

αθ

(I-1)(K-1)
(J-1)(K-1)

0

1

0

σε2 + Jσθβ2

(αθβ)ijk

(I-1)(J-1)(K-1)

0

1

0

σε2 + σαθβ2

1

1

1

σε2 (not estimable)

Total

𝑏−1

∑ ∑ (𝛼𝛽) 2

(θβ)jk

εijk

∑𝑘 𝛽𝑘 2

IJK-1

After all this preliminary work, we can finally build up the ANOVA table for
Model 1 is as Table 2.2.2.
Moreover, setting up EMS table as Table 2.2.1 is extremely helpful in
determining which effects are comparable and is valid to be tested by using hypothesis
testing. We can compare EMS directly from Table 2.3.2. For example, EMSs of αi and
(αθ)ij are σε2 + Kσαθ2 + JK
and JK

∑𝑖 𝛼𝑖 2
𝑚−1

∑𝑖 𝛼𝑖 2
𝑚−1

and σε2 + Kσαθ2, respectively. They share first two terms

is the only thing that makes the difference, which gives the clue that it may

be easy to do testing for αi, and that actually, it represents the fixed effect in whole-plot
stage. Similarly, it is not hard to notice that all fixed factors and their interaction effect
can be easily tested by our common used F-test. There is one important aspect needs to
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be pointed out when doing F-test for this kind of Split-plot design. We have referred to
the term “stages “many times; it is significant to figure out which stage the effect you
want to test located in since the “stage” determine the denominator you would use if you
need to do an F-test.

Table 2.2.2 ANOVA Table for General Split-plot Model
Source
D.F.
S.S.
M.S.
of Variance
Species
I-1
SSSpecies
MSSpecies
Treatment

J-1

SSTreatment

Whole-plot error

(I-1)(J1)
K-1

SSEW

MSEW

SSTime

MSTime

Time
Interaction effect
between
Species&Treatment
Interaction effect
between Treatment
& Time
Split-plot error
Total

(I-1)(K1)

SSSpecies×Treatment MSSpecies×Treatment

(J-1)(K1)

SSTreatment×Time

MSTreatment×Time

(I-1)(J1)(K-1)
IJK-1

SSES

MSES

F-Ratio
MSSpecies/MSEW

MSTime /MSES
MSSpecies×Treatment
/MSES

SSTO

Based on those values in Table 2.2.2, we can do the following tests for fixed
effects:
𝐻0 : 𝛼𝑖 = 0 𝑣𝑠. 𝐻𝑎 : 𝛼𝑖 ≠ 0, by using 𝐹0 =

𝑀𝑆𝑆𝑝𝑒𝑐𝑖𝑒𝑠
⁄
𝑀𝑆𝐸 𝑊

𝐻0 : 𝛽𝑘 = 0 𝑣𝑠. 𝐻𝑎 : 𝛽𝑘 ≠ 0, by using 𝐹1 =

𝑀𝑆𝑇𝑖𝑚𝑒
⁄
𝑀𝑆𝐸 𝑆

𝐻0 : (𝛼𝛽)𝑖𝑗 = 0 𝑣𝑠. 𝐻𝑎 : (𝛼𝛽)𝑖𝑗 ≠ 0, by using 𝐹2 =
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𝑀𝑆𝑆𝑝𝑒𝑐𝑖𝑒𝑠×𝑇𝑖𝑚𝑒
⁄
𝑀𝑆𝐸 𝑆

Notice that the interaction effect between Time and Treatment is not valid to do
an F-test and the term (αθβ)ijk is used as split-plot error for F-test. We can start to think
about if the related terms in Model 1 is really necessary to list out separately or not. In
statistics, it is always advantageous to use fewer parameters than more. Consider to
modify Model 1 as this:
Model 2: Yijk = µ + αi + θj + (αθ)ij + βk+ (αβ)ik + εijk
where
αi: whole-plot factor (Species) main effect;
θj: Treatment effect;
(αθ)ij: whole-plot error;
βk: split-plot factor (Time) main effect;
(αβ)ik: interaction effect between Species and Time;
εijk: split-plot error;
Assumptions are hold for θj, (αθ)ij and εijk as what we stated in Model 1. This
simplified model combines interaction effects of TIME and TREATMENT, and
SPECIES and Treatment into εijk, and it satisfies entirely to cases if those two interaction
effects listed above are not of the interest. The related procedures for sum of squares and
EMS are nothing but a little bit change in whole plot terms as what we did for Model 1.
Here, it no need to write down again.

Section 2.3 Matrix Form
For both mixed model and linear model, it is more convenient to use matrix form
to rewrite the specific models. Matrix form formula is helpful to distinguish fixed
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variables from random variable, comparing with regular model formulas as what we used
previously in this chapter. For mixed model, such as split-plot model here, model allows
the existence of both fixed and random effects. But in specific case, one of them may
missing. Like the model we used for our sample data, all factors are fixed actually. So the
model we generalized here don’t have random variables. In order to apply matrix notation
to general split-plot model, let ignore the original experiment design and assume 𝜃𝑗 are
random, and others are fixed.
⃗ represents matrix of all depending variable, such as Yijk in our model.
Usually, 𝑌
⃗⃗⃗⃗𝑘 , ⃗⃗⃗⃗⃗⃗⃗⃗
𝛽 contains all fixed effect parameter vectors, for instance, ⃗⃗⃗
𝛼𝑖 , 𝛽
𝛼𝛽𝑖𝑘 in Model 2. 𝑍 is a
matrix filled with 1’s and 0’s depending on specific model and experiment requirement.
⃗⃗⃗𝑗 , and 𝑒 is matrix of
⃗ is a matrix containing all random effect variable vectors, such as 𝜃
𝑈
all error terms. The details and properties of those matrices above will be shown in
Appendix III. Our reduced Model 2, here, can be written as
⃗ = 𝑋 𝛽 + 𝑍𝑈
⃗ + 𝑒, where
𝑌
𝑦111
⋮
𝑦116
𝑦121
⋮
⃗ = 𝑦126 , 𝑋𝛽 =
𝑌
𝑦211
⋮
𝑦216
𝑦221
⋮
(𝑦226 )

𝛼1
⋮
⋮
⋮
⋮
𝛼1
𝛼2
⋮
⋮
⋮
⋮
(𝛼2

𝛽1
⋮
𝛽6
𝛽1
⋮
𝛽6
𝛽1
⋮
𝛽6
𝛽1
⋮
𝛽6

𝛼𝛽11
𝜃1
𝜀111
⋮
⋮
⋮
𝜃1
𝜀116
𝛼𝛽16
𝜀121
𝜃2
𝛼𝛽11
⋮
⋮
⋮
𝛼𝛽16
⃗ = 𝜃2 , and 𝑒 = 𝜀126
, 𝑍𝑈
𝜀211
𝜃1
𝛼𝛽11
⋮
⋮
⋮
𝜀
216
𝜃1
𝛼𝛽16
𝜀221
𝜃2
𝛼𝛽11
⋮
⋮
⋮
(
𝜀
226 )
(𝜃2 )
𝛼𝛽16 )
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Section 2.4 SAS for Split-plot Design
The proper analysis of a split-plot design must account for the fact that treatments
applied to main plots are subject to larger experimental error than those applied to
subplots. Hence, different means squares must be used as denominators for the
corresponding F-ratios. Also, many means comparisons of potential interest have error
terms that are linear combinations of mean squares. While PROC GLM is useful for
determining expected mean squares, PROC MIXED is better suited to analyze split-plot
design. (Littell 2006)
Based on general analysis in last section, TREATMENT is considered as random
and Model 2 is appropriate to use here. Both PROC GLM and PROC MIXED can be
used. In last section, EMS table (Table 2.2.1) and ANOVA table (Table 2.2.2) have been
set up by pure structure analysis and computation. In SAS, those complex procedures can
be done with several statements.
Doing analysis with PROC GLM in SAS.
proc glm;
class species treatment time;
model Y= species treatment species*treatment time species*time/ss3;
test h=species e=species*treatment;

/* random treatment species*treatment/test; */

run;
In PROC GLM, the TEST option “test h=species e=species*treatment” is used to
do hypothesis for species (whole-plot factor) and it implies “species*treatment” is the
term used as error term (whole-plot error).
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The MSE for GENE00001 sample is shown on fourth column of Table 2.4.1. The
result matches what we got in Section 2.1. In the Source column, the results point out
which mean squares we need for further analysis and testing. Note that
SPECIES×TREATMENT is listed as a source, which means the F-ratio 𝑀𝑆

𝑀𝑆𝑆𝑝𝑒𝑐𝑖𝑒𝑠

𝑆𝑝𝑒𝑐𝑖𝑒∗𝑇𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡

need to be computed for testing species.
However, the F-ratio is not valid statistically in default due to the special error
term SPECIES×TREATMENT is used. It would be better to add RANDOM statement
here to fix this default problem. After adding RANDOM statement, SAS would output
the correct ANOVA table.

Table 2.4.1 SAS output of split-plot GENE00001 sample
Source
DF Type III SS Mean Square F Value

Pr > F

species

1

0.0259

0.0259

0.81 0.5331

treatment

1

0.0002

0.0002

0.03 0.8882

Error

1

0.1501

0.0300

species*treatment

1

0.0322

0.0322

3.43 0.1232

time

5

0.0638

0.0127

2.65 0.1539

species*time

5

0.1078

0.0215

1.22 0.4150

treatment*time

5

0.0550

0.0110

1.89 0.2505

Error: MS(Error)

5

0.0259

0.0259
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As the conclusion made from ANOVA of standard designs, F Values indicate
significance of all listed sources.
Since the model contains fixed factors and random factor, it is a perfect mixed
model. PROC MIXED is recommended. It can be done by some even simpler statements.
proc mixed;
class species treatment time;
model Y= species treatment species*treatment/ddfm=satterth;
random time species*time;
run;
In PROC MIXED procedure, only fixed terms are listed in MODEL statement
and error terms go in the RANDOM statement. SAS don’t need to be told which error
term to be used for testing.
The specifics of a given design should determine whether to consider the blocking
criterion as fixed or random, but no need here. Furthermore, more statements, such as
CONTRAST or ESTIMATE, can be added appropriately to do further analysis as needed.
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CHAPTER 3: SPLIT-PLOT APPLICATION IN GRAPEVINE EXPERIMENT

After discussing split-plot and its related designs, we can start to work on
RAWDATA. In this chapter, we will use split-plot design to model the grapevine
experiment, and then we will use an appropriate model expression to examine gene
behavior with other statistical techniques.

Section 3.1 Experiment Description
Wild grapevines represent important genetic resources. During the past century, a
broad range of wild bunch grape species (subgenus Euvitis) form North America and East
Asia have been used to introgress genes for pest and pathogen resistance and
environmental tress tolerance into cultivated scion and rootstock varieties (Alleweldt et
al, 1990). Current trends toward reducing chemical input and relying more on biologicalbased disease resistance in grape cultivation makes the biological diversity of the wild
grapevines even more relevant (Bisson et al, 2002). Understanding the molecular basis of
this diversity will accelerate progress in harnessing the biological resources in Vitis. To
our knowledge, genome-scale transcript level variation has not been examined in
different Vitis species or different Vitis vinifera genotypes. An assessment of gene
expression differences in various grapevine species will provide information about the
role transcriptional regulation may play in phenotypic variation and adaptation. Vitis is
highly heterozygous genus (Reisch and Pratt, 1996). At the molecular level,
heterozygozity manifests itself in DNA sequence divergence among the different species
and between haplotypes of V. vinifera, as evidenced by results from molecular marker-
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based genotyping, and form sequencing of allelic variants for genes and bacterial
artificial chromosome inserts (Aradhya et al, 2003; Salmaso et al, 2004; Adam-Blondon
et al, 2005).
In present work, we conducted comparative mRNA abundance measurements in
two grapevine genotypes, V. aestivalis Norton and V. vinifera Cabernet sauvignon. V.
aestivalis Norton is a cultivated variety of North American origin. It is typical
representative of North American grapevine species in that it is highly resistant to such
economically important diseases as black rot, powdery mildew, and downy mildew, and
is able to tolerate the insect pest phylloxera. V. vinifera Cabernet, on the other hand, is a
Eurasian grapevine species which highly susceptibility to the above disease and pest.
Furthermore, the two grapevines are distinctly different in a number of other features,
including morphologically and physiological traits as well as fruit characteristics.
To test the tolerance of disease for both species, V. vinifera Cabernet sauvignon
and V. aestivalis Norton, researchers raised two sets of plants in two separate growth
chambers, controlling all conditions the same. In each set of plants, there are 60 V.
vinifera Cabernet sauvignon and 60 V. aestivalis Norton. To observe the plants’ behavior
under different treatments, researchers applied inoculation with E. necator conidiospores
to all plants raised in growth chamber A and mock inoculation was applied to those
plants in growth chamber B. For each group containing 60 plants as we described above,
they assigned numbers to each plants, then randomly chose 10 numbers without
replacement and picked leaves from plants assigned with those 10 numbers to make a
batch. An observation make on each batch yields a GeneChip. This procedure did six
times at 0, 4, 8, 12, 24, 48 hours. On each chip, measurements for each of the 16436
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genes were obtained. Here, each GeneChip generates a typical RNA microarray, and
genes in the microarray are addressed by a unique identification number. We call them as
gene ID’S. Throughout, CR1, CR2, and CR3 stands for three replicates of V. vinifera
Cabernet sauvignon and NR1, NR2, and NR3 are those for the three replicates of V.
aestivalis Norton. Therefore, researchers got 2×2×6×3 = 72 observations for each of
16436 genes. The data set for this experiment is denoted as RAWDATA.

Section 3.2 Preliminary Data Modifications
Normalization. For some data, we don’t need to normalize the observations. Why
do we perform normalization here? As what we mentioned in section 3.1, RAWDATA is
a Microarray data. Microarray data are noisy due to the co-existence of genuine
biological variations (signal) and noise (Wu 2005). Signal is what we desire to use to
distinguish one sample from another, but noise can be raised by any step of experiment,
which may hide useful information and mislead the further data analysis, somehow. To
make downstream analysis more precise, we have to minimize the effect of noise.
The technique used to minimize noise here is normalization. There is variety of
methods to normalize data. In RAWDATA, there are 72 samples due to the original
experimental design of researchers. Here, we choose a two-step method to normalize data
sample by sample. Firstly, using log2-transformaiton to decrease magnitudes of signals.
Raw data may be extremely skewed. Doing log2-transformation, the magnitude of data
decreases, which minimizes part of the noise and forces transformed data to be more
normally distributed. For log2-transformation, 𝑙𝑜𝑔2 (𝑠𝑖𝑔𝑛𝑎𝑙) is enough for most cases,
here we prefer to modify it to be 𝑙𝑜𝑔2 (𝑠𝑖𝑔𝑛𝑎𝑙 + 1) since there are zeros in RAWDATA.
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To check if this transformation method works or not, we pick all observations of the first
biological replicate at time point 0 of both species, CS and N, separately, as samples. In
Figure 3.1, the histograms of raw samples are displayed. The graphs are extremely skewed,
which implies that the noise effect would be strong and outstanding if we use raw data to
do further analysis.
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Figure 3.1 Histograms of signals in CR1 and NR1 observed at 0 hour
Figure 3.2 shows the histograms of sample data after doing log2-transformation.
Even thoughthey are not perfectly bell-shaped, these two histograms are approximately
normal and less skewed as what they were in Figure 3.1. By comparing Figure 3.1 and
3.2, the benefit of log2-transformation is obvious. On the other hand, noise contributes
the residual portion, statically. Normal QQ-plot is usually used to identify if the
transformed variable is approximately normal. The general rule is that if the graph is
approximately a straight li ne, the data set can be approximately described as normally
distributed; otherwise, the residual effect of this specific data set may be noisy. In the
graph on the left, the data is heavy-tailed normally distributed, and right graph shows the
data is light-tailed normally distributed, which implied the log2-transformation is actually
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improve the data quantity for further analysis. Even log2-transformed data has already
normalized the data and made them light-tailed normally distributed, it is not standard
enough. We need second step here.
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Figure 3.2 Histograms of signals in log2-transformed NR1 and in log2-transformed NR1
measured at 0 hour
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Figure 3.3 Before and after QQ-plots for CR1 at 0 hour with log2-transformation
Secondly, We can try to standardize this dataset again by calculating z-score,
𝑡𝑟𝑎𝑛𝑠𝑓𝑜𝑟𝑚𝑒𝑑 𝑑𝑎𝑡𝑎−𝑠𝑎𝑚𝑝𝑙𝑒 𝑚𝑒𝑎𝑛
𝑠𝑎𝑚𝑝𝑙𝑒 𝑑𝑒𝑣𝑖𝑎𝑡𝑖𝑜𝑛

, sample by sample for all 72 samples. The importance of

this step is to make data more standard to do analysis and avoid useless noisy effects.
Similarly, we can show the effects of this step by histograms and Normal Q-Q plots, as
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what they are for the first step. With the help of this two-step method, the normalized
data is marked as THESIS in Dataset section.
After normalizing thesis data, we can make a scatter matrix to check the
correlation among six time points on same subject. Taking CR1 as an example, the results
are shown in Figure 3.4. For any two time points, they are strongly correlated and there is
not outstanding pattern in terms of time lags showing on the scatter matrix in Figure 3.4.
This fact supports our general experiment modelling in Chapter 1 and the basic
knowledge of correlation structure for split-plot design in Chapter 2.

-2 -1

0

1

2

3

-3 -2 -1 -0 1

2

3

-2 -1

0

1

2

3
3
2
1
-0
-1
-2
-3

Z.trans.CR1.0H

3
2
1
0
-1
-2

Z.trans.CR1.4H

3
2
1
-0
-1
-2
-3

Z.trans.CR1.8H

3
2
1
-0
-1
-2
-3

Z.trans.CR1.12H

3
2
1
0
-1
-2

Z.trans.CR1.24H

3
2
1
0
-1
-2

Z.trans.CR1.48H

-3 -2 -1 -0 1

2

3

-3 -2 -1 -0 1

2

3

-2 -1

0

1

2

3

Figure 3.4 Scatter matrix for CR1 for all six time points
Reshaping. Notice that in NORMDATA, the data set follows a multivariate
structure, which is not very convenient in many analyses. To minimize trouble in further
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analysis, we will reshape the data set into univariate structure. Using PROC IMPORT
statement, we can import our raw data into SAS Software and reshape it. In this
procedure, some simple statements with their options may be used here, such as PROC
TRANSPOSE, DATA, etc. The details and commands of statements will show up in
Appendix V. The reshaped data will replace the previous dataset named as
NORMDATA.

Section 3.3 General Modelling Procedure
This experiment includes factors SPECIES, TREATMENTS, TIMES, and
REPLICATES. One thing we need to notice is that the replicates here are not real
replicates as we knew for standard designs. These three replicates are sampled from the
same biological subjects, which is called biological replicates. And again, the
REPLICATES factor is nested within TIMES factor.
Considering the example in Chapter 2, we can apply similar philosophy in our
experiment. All possible effects are main effects of SPECIES, TREATMENTS, and
TIMES, and all their interactions, and also the nested effect of REPLICATES nested
within TIMES effect. Mathematically, this model can be written as following
Model 3: 𝑦𝑖𝑗𝑡𝑘 = µ + 𝛼𝑖 + 𝛽𝑗 + (𝛼𝛽)𝑖𝑗 + 𝜃𝑡 + (𝛼𝜃)𝑖𝑡 + (𝛽𝜃)𝑗𝑡 + (𝛼𝛽𝜃)𝑖𝑗𝑡 + 𝛾𝑘(𝑖𝑗𝑡) +
𝑒𝑖𝑗𝑘𝑡
where 𝑦𝑖𝑗𝑡𝑘 denote the signal for kth measurement at tth time point of ith species with jth
treatment for any 𝑖 = 1, 2, 𝑗 = 1,2, 𝑡 = 1, … ,6, 𝑘 = 1,2,3; µ is the grand mean; 𝛼𝑖 , 𝛽𝑗 ,
(𝛼𝛽)𝑖𝑗 , 𝜃𝑡 , (𝛼𝜃)𝑖𝑡 , (𝛽𝜃)𝑗𝑡 , (𝛼𝛽𝜃)𝑖𝑗𝑡 are main and interaction effects in terms of
SPECIES, TREATMENTS and TIMES factors; 𝛾𝑘(𝑖𝑗𝑡) represents the nested kth
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REPLICATES effect; and 𝑒𝑖𝑗𝑘𝑡 is the random error terms following i.i.d. 𝑁(0, 𝜎 2 ). Other
basic assumptions are the similar as those for the general model stated in Chapter 2.
Recall split-plot design we discussed in Chapter 2, we always identify whole-plot
factor, split-plot factor, and error terms in each stage, respectively. It is reasonable to
believe that, in this case, SPECIES and TREATMENTS are set up as a 2 factorial design,
and that they are whole-plot factors, at the same time; and TIMES can be regarded as
split-plot factor. The biological replicates are basically nothing but repeated measures
here. We will discuss the reason later after we check Model 3.
Notice that, for each GeneChip, the degree of freedom on left and right sides of
model are not equal, we can show this in Table 3.3.1. There is no doubt that the degree of
freedom in right hand side is 71 since we have 72 signals for each GeneChip. On the right
hand side, total degree of freedom except that for error term is 71, as well. Table 3.3.1
suggests that error term has been partitioned into those error terms in stages of split-plot
design. Therefore, we can consider to delete the general error term and modify our
assumption above. The modified model is
Model 4: 𝑦𝑖𝑗𝑡𝑘 = µ + 𝛼𝑖 + 𝛽𝑗 + (𝛼𝛽)𝑖𝑗 + 𝜃𝑡 + (𝛼𝜃)𝑖𝑡 + (𝛽𝜃)𝑗𝑡 + (𝛼𝛽𝜃)𝑖𝑗𝑡 + 𝛾𝑘(𝑖𝑗𝑡)
Now, let us import THESIS into SAS to check rest terms. In SAS, we can use both PROC
GLM and PROC MIXED to deal with a certain split-plot design. Once correct codes are
written down, results from both procedure are the same.
In this case, by using PROC GLM, we can write following statements:
Proc glm data=NORMDATA;
class ID SPE TR T REP;
model Y = SPE TR SPE*TR T SPE*T T*TR SPE*TR*T REP(SPE*TR*T)/SS3;
test h=TR E=SPE*TR;
random SPE*TR REP(SPE*TR*T)/test;
run;
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Table 3.3.1 Degree of freedom for Model 3
Degree of
Source in Left Side
Sources in Right side
Freedom
𝛼𝑖

𝑦𝑖𝑗𝑡𝑘

Total

72-1

71

Degree of
Freedom
2-1

𝛽𝑗

2-1

(𝛼𝛽)𝑖𝑗

(2-1)(2-1)

𝜃𝑡

6-1

(𝛼𝜃)𝑖𝑡

(2-1)(5-1)

(𝛽𝜃)𝑗𝑡

(2-1)(5-1)

(𝛼𝛽𝜃)𝑖𝑗𝑡

(2-1)(2-1)(5-1)

𝛾𝑘(𝑖𝑗𝑡)

2×2×6×(3-1)

𝑒𝑖𝑗𝑘𝑡

?

Total

71+?

The first output getting from these statements is the EMS table (Table 3.3.2) for
each term in model, which is exactly same as what we did in Chapter 2 and in Appendix
II. Noting that we only used the data of the first gene. We discussed about how to use
EMS table to determine the stage errors. See the results in EMS column of Table 3.3.2, it
is clear now that SPE*TR (interaction effect of SPECIES and TREATMENTS) is the
whole plot error and REP (SPE*TR*T), REPLICATES effect nested within SPECIES,
TREATMENTS and TIMES factors, is the split-plot error. One thing we need to pay
special attention here is if we take all genes’ observations into consideration the
coefficients would be huge since SAS takes gene ID as a variable in default. This is not
reasonable in experiment. If only those observations of one certain gene (such as GENE
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00001) were concerned, the results would exactly the same as what we calculated in
Chapter 2. And our assumption is whole-plot error follows i.i.d. 𝑁(0, 𝜎𝑤 2 ) and split-plot
error follows i.i.d. 𝑁(0, 𝜎𝑠 2 ), and they are mutually independent.

Table 3.3.2 SAS output of EMS for model in Model 4
Source

Type III Expected Mean Square

SPE

Var(Error) + Var(REP(SPE*TR*T)) + 18 Var(SPE*TR) +
Q(SPE,SPE*T SPE*TR*T,)

TR

Var(Error) + Var(REP(SPE*TR*T)) + 18 Var(SPE*TR) +
Q(TR,TR*T,SPE*TR*T)

SPE*TR

Var(Error) + Var(REP(SPE*TR*T)) + 18 Var(SPE*TR) +
Q(SPE*TR*T)

T

Var(Error) + Var(REP(SPE*TR*T)) +
Q(T,SPE*T,TR*T,SPE*TR*T)

SPE*T

Var(Error) + Var(REP(SPE*TR*T)) + Q(SPE*T,SPE*TR*T)

TR*T

Var(Error) + Var(REP(SPE*TR*T)) + Q(TR*T,SPE*TR*T)

REP(SPE*TR*T) Var(Error) + Var(REP(SPE*TR*T))

Another output is the ANOVA table (Table 3.3.3), which directly implies that all
terms of model 4 are significant, since all p-values are extremely small.
When using PROC GLM for split-plot design, we have noticed that only one error
term (usually, the error in the very last stage) is used to calculate all F values in the
default, so only those F values of effects in very last stage is correct in default results, for
instance, T, SPE*T, and TR*T in Table 3.3.3. We need to tell SAS which error term we
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want to use when calculating F value for specific effect. TEST option here is add to
specify which one to do hypothesis testing and which stage error to use.
Table 3.3.3 ANOVA for model in model 4 by using PROC GLM
Source

DF

Type III SS Mean Square F Value

Pr > F

SPE

1 16517.86240 16517.86240 1868.59 <.0001

TR

1

350.21838

350.21838

39.62 <.0001

SPE*TR

1

585.31561

585.31561

66.21 <.0001

T

5

991.62840

198.32568

22.44 <.0001

SPE*T

5

171.16638

34.23328

3.87 0.0016

TR*T

5

218.52642

43.70528

4.94 0.0002

53

6225.59124

117.46399

13.29 <.0001

REP(SPE*TR*T)

Noting that random term, REP (SPE*TR*T) here, shows neither in MODEL
statement nor in RANDOM statement. In this experiment, we can write code as below in
SAS and output shows in Table 3.3.4.
Proc mixed data=NORMDATA method=ml;
class ID SPE TR T REP;
model Y = SPE TR SPE*TR T SPE*T T*TR;
random SPE*TR;
run;
As we said above, the results should be the same in both procedures. Even though
some p-values in PROC MIXED procedure don’t show up appropriately and some pvalues in PROC GLM is not even correct in default, we can still see the results for T,
SPE*T, and TR*T are the same, and we have ensured these values are correct in default.
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That is enough to prove both procedure function well and the model in model 4 is
appropriate tested by our dataset.
Table 3.3.4 ANOVA table for model in model 4 by using PROC MIXED
Type 3 Tests of Fixed Effects
Effect

Num DF

Den DF

F Value

Pr > F

SPE

1

0

1867.46

.

TR

1

0

39.60

.

SPE*TR

1

0

66.18

.

T

5

12E5

22.42

<.0001

SPE*T

5

12E5

3.87

0.0016

TR*T

5

12E5

4.94

0.0002

Section 3.4 Computation of Gene-Specific Significance Models
After finishing general modelling, we need to focus on the main purpose of our
experiment, which is to test which gene(s) expression is/are significantly different from
others in terms of TREATMENTS. In order to reach this goal, we need to apply our
model in model 4 to each GeneChip and observe the results one by one. First of all, we
need to sort our data NORMDATA in SAS to perform mixed model ANOVA for
individual genes. In SAS, SORT procedure can be applied here.
Proc sort data=NORMDATA;
by ID SPE TR T REP;
run;
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Under this procedure, our data NORMDATA are sorted by ID, then by SPECIES,
then by TREATMENTS, etc. For our purpose, only ID one really matters, as this ensures
that all of the values for each clone are grouped into contiguous block (Gibson and
Wolfinger 2004). And then we can perform gene-specific ANOVA. Typing the following
text into the editor pane of SAS and submit it:
ods exclude all;
ods noresults;
proc mixed data = NORMDATA;
by ID;
class ID SPE TR T REP;
model Y=SPE TR SPE*TR T SPE*T T*TR SPE*TR*T/ outp= NormData1;
random REP(SPE*TR*T);
lsmeans SPE TR SPE*TR T SPE*T T*TR SPE*TR*T/diff;
ods output covparms=COVparms tests3=Tests3 lsmeans=lsms diffs=Diffs;
run;
ods exclude none;
ods results;
By running this set of statements, SAS would automatically apply model to 16436
genes one by one and provide ANOVA table for each Gene ID in Test3 results. Test3
results are shown in Table 3.4.1. In this set of ANOVA tables, only items we concern
about are the p-values for TREATMENTS effect, because it implies the significance of
TREATMENTS effect. Instead of showing the huge amount of results here, we pick the
results of 10 genes in terms of the p-values of TREATMENTS effect to explain.
In column ProbF, we can notice that values for all genes except first and fourth
ones are relatively large, over 0.1. For first gene, p-value = 0.0201, which implies this
gene expresses differently under treatments if we take 0.05 as level of significance.
Similarly, for the fourth gene, it p-value is 0.0677. It is a little bit higher than 0.05, but it
is possible to consider it is differently expressed if a higher biological significant level is
chosen. On the other hand, for the rest of eight genes, their p-value is considered to be
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large in most cases, statistically. We can conclude that their TREATMENTS effects are
not significant, and furthermore, their gene expressions don’t change much under
different treatments in this experiment. Depending on the choice of significance levels,
gene expression can be easily determined from the results as Table 3.3.1. This analysis
can be generalized to all 16436 genes to check if their TREATMENTS effects are
significant or not. If yes, we can pay special attention to it in further research to explore
their special properties.
Table 3.4.1 Brief ANOVA for first 10 genes in terms of TREATMENTS effect
Obs ID
Effect NumDF DenDF FValue ProbF
1 GENE00001 TR

1

48

5.78 0.0201

2 GENE00002 TR

1

48

0.09 0.7659

3 GENE00003 TR

1

48

1.61 0.2107

4 GENE00004 TR

1

48

3.50 0.0677

5 GENE00005 TR

1

48

0.21 0.6461

6 GENE00006 TR

1

48

0.32 0.5733

7 GENE00007 TR

1

48

0.92 0.3418

8 GENE00008 TR

1

48

2.49 0.1211

9 GENE00009 TR

1

48

0.10 0.7537

10 GENE00010 TR

1

48

2.49 0.1213

Section 3.5 Further Concern
In previous sections, we did analysis by modelling data as split-plot. The results
are quite clear in procedures; however, we also noticed that there are many potential
properties ignored when using split-plot. For example, the split-plot design never
considers the possible reason why a researcher did measurements at six different time
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points and the possible biological pattern implied by measurements. Actually, we can do
some brief analysis based on time. Recall that in Figure 3.4, it is no problem that
correlation between any two time points are extremely high; however, we may have
already noticed that the plot is slightly spread out as the time difference increases at first
four time points, and that the shape of scatter plots are similar among 0 hour, 24 hour,
and 48 hours. Those can be concluded as an obscure pattern saying that the correlation
decreases slightly with the increasing of time lag among the first three time points and
that the correlation among 0 hour, 24 hour, and 48 hours are relatively stable. This pattern
can be clearly displayed by covariance correlation table. Randomly pick all observations
of CS with MOC applied, the correlation table is given by S-plus in Table 3.5.1.

Table 3.5.1 Correlation table for CS under treatment MOC at six time points
0 hour
4 hours
8 hours
12 hours
24 hours
48 hours
0 hour

1.0000000

4 hours

0.9787216 1.0000000

8 hours

0.9397674 0.9720687 1.0000000

12 hours

0.9308847 0.9418207 0.9682751 1.0000000

24 hours

0.9667132 0.9626963 0.9230444 0.9029759 1.0000000

48 hours

0.9462432 0.9430237 0.9010002 0.8883521 0.9822352 1.0000000

Due to the property of correlation between two variables, values in cells are
symmetric. For instance, correlation between 4 hours and 24 hours is exactly same as
what it is for 24 hours and 4 hours. In the second column (0 hour column) of Table 3.4.1,
we can see the correlation declines in time interval [0, 12], from 1.0000000 to 0.9308847;
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at the same time, corr(0 hour, 24 hours) raised up to 0.9667132 and corr(0 hour, 48
hours) = 0.9462432. This fact may imply a cycling biological pattern, such as the diurnal
cycle.
In split-plot design, this special pattern is totally ignored, since split-plot design
has a symmetric component assumption about measurements made from same subjects.
To make full use of this new potential information, more precise models, such as
repeated-measures design, can be considered if current results could not satisfy the
researchers’ requirements. Briefly, the repeated measurement design provides more
flexibility on component assumption on the measurements made from the same
experiment units. Next, we will spend a chapter to discuss repeated measurement
experiment design.
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CHAPTER 4: REPEATED-MEASURES DESIGN

In the previous chapter, we discussed Split-plot Design. There is another
commonly used experimental design with some special property and advantages. It is the
Repeated Measurements Design. In this chapter, we will introduce knowledge related to
Repeated Measurements Design and compare it with Split-plot Design.

Section 4.1: Background
In recent decades, researches have been expanding from natural sciences to social
and behavioral sciences. People are frequently chosen to be subjects of research. A good
example is doing survey by questionnaire.
The researchers design different questions for different group of people based on
their different occupations, regions, levels of education, and so on. And it is rarely that
they pick a single person in each group to finish their survey because it would waste the
effort of researcher developer. Multiple people would be randomly picked. This kind of
research design implies their potential concerns, which are people in same group share
some common parts and also the difference among people in same group can make the
research more precise.
The example above demonstrates that selecting multiple people may be useful to
improve research somehow. But how does this kind of design help? Doing survey can be
looked as a kind of experiment. And then, we can review this survey statistically.
Different versions of questionnaires are similar to different kinds of treatments applied in
experiment. We will show details in following sections in this chapter.
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Section 4.2 Statistical Introduction
In the example of last section, the group we described in last section are typically
called as experimental units, or subjects in statistics. Researchers apply each treatment to
each subject and get multiple observations (different results from different people in same
group) for each subject. Such a design is called a Repeated Measures Design
(Montgomery, 1997). Repeated measures refers to multiple measures on the same
experimental unit. Usually, repeated measures are made over time, but they can be over
space. A very common situation is for treatments to be applied to experimental units in a
completely randomized design. Then measurements are made at several different times
(Littell, et al. 2002). Let’s consider the measurements made in a sequence of time point.
Those observations get from same subjects should be related and dependent since they
share some common properties from the subject. And also, observations which are
measured closer in time should have a stronger impact than those get measured far away
in time. These abstract thinking can be concluded as the variance and covariance
structure, which is exactly the special property for Repeated measures design.

Section 4.3 Model
We mentioned variance and covariance structure in previous section, here we will
explain it more specifically with example and its model. For instance, a medical
institution plans to examine the effects of n drugs for insomnia patients. n drugs are
assigned to n groups each randomly. Researchers then measure the time taking to fall
asleep daily in following t successive days for patients with the help of each kind of
drugs.
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The experiment units, or subjects, are patients here. Drugs are considered to be
treatments. It’s clear that the repeated measures are taking by times. The effects we can
conclude here are DRUG, TIME, DRUG*TIME. The model for this example is
𝑦𝑖𝑗𝑘 = µ + 𝛼𝑖 + 𝛽𝑘 + (𝛼𝛽)𝑖𝑘 + 𝑒𝑖𝑗𝑘
where
µ is the overall mean; 𝛼𝑖 , 𝛽𝑗 , (𝛼𝛽)𝑖𝑗 are 𝑖 𝑡ℎ drug effect, 𝑘 𝑡ℎ time effect and their
interaction effect, respectively; 𝑒𝑖𝑗𝑘 ’s are random error for 𝑗 𝑡ℎ patient taking 𝑖 𝑡ℎ drug at
𝑘 𝑡ℎ day.
Directly from the form of model, two questions are raised:
1. Different patients should make difference; however, no main or even interaction
effect involving patient effect. How could this model explain the variability of
different patient?
2. This model is exactly the same with certain kind of 2 factorial design. Why do we
say this model works for Repeated measures design?
These two question can be answered by the special properties of error term 𝑒𝑖𝑗𝑘 .
These properties are called variance and covariance structure of 𝑒𝑖𝑗𝑘 . Since time factor is
not randomly assigned, we cannot assume error terms are independent generally as what
we do for other standard design, or even not as Split-plot design.

Section 4.4 Variance and Covariance Structure
As what we said in section 2 of this chapter, measurements made on same
subjects share common property from subject and measurements influent others stronger
when they are closer in time, in space, or in condition. Formally speaking, those two
conclusions are two aspects of covariance structure in errors:
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1. Measurements made from same subject are stronger, positively in most cases,
correlated than those made from different subjects. (Sometimes, this aspect is
called as between-subject variation)
2. Measurements made closer in time, in space, or under conditions are highly
correlated than those made far apart. Correlation can follow various structure, it is
not always linear.
Due to the importance of covariance structure for repeated measures design, this
structure has to be considered and specified in doing statistical analysis technique. Many
methods have been developed to deal with covariance structure for repeated measures
design. We introduce three general methods.
Univariate ANOVA. This approach is also known as split-plot in time ANOVA.
Why so? Univariate ANOVA treats repeated measures data same as split-plot data.
Subjects and time factors are matching with whole plot units and split plot factors, which
means only the first aspect of covariance structure is considered in analysis. It’s not
always appropriate for repeated measures data, but if correlations between measures on
the same subject are the same regardless of time proximity, then this approach is a
perfectly good method of analysis (Littell, et al. 2006).
Analysis of Contrasts. Instead of doing analysis on data directly, analysis of
contrasts analyzes linear combinations of data on each subject. In this approach, we
introduce regression concept by considering measurements on same subject are regressed
on time. The slopes of these regression line are treated as the effects of time on each
subject. By doing analysis of these slopes, we can analyze the effects of treatments on
these time effects. Since the covariance structure is not considered here, this approach is
not optimal.
Mixed-model Methodology. This approach contains two steps. The first step is
estimating covariance structure. Second is substituting estimated covariance structure into
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the model. And then we can use (generalized) least-squared method to assess treatment
and time effects. However, estimation of covariance structure is not an easy job to do.
With the development of statistical programs, this complex estimation can be done by
computer software, for instance, PROC MIXED in SAS.
For the convenience of writing down, matrix forms are introduced in almost all
aspects of statistics. Matrix form is applied to statistical models. Details are shown in
Appendix III. In terms of matrix form, modelling covariance structure is finding the form
of G and 𝑹𝒊𝒋 , portions of R that corresponds to an individual subject. There are many
candidate covariance structures to choose from.
Simple covariance structure is as the name implies, which is the simplest
structure. It assumes all measurements (observations) are independent no matter they are
made on same subjects or not, and variance of measurements are homogenous. Then the
correlation function is 0 in this case. Backing to example in section 3, simple covariance
structure as
𝑐𝑜𝑣(𝑦𝑖𝑗𝑘 , 𝑦𝑖𝑗𝑙 ) = 0 𝑖𝑓 𝑘 ≠ 𝑙 𝑎𝑛𝑑 𝑣𝑎𝑟(𝑦𝑖𝑗𝑘 ) = 𝜎𝑆𝐼𝑀 2
Recall the matrix form in Appendix III,𝐆 = 𝟎 and 𝑹𝒊𝒋 = 𝜎𝑆𝐼𝑀 2 𝑰, where I is an
identity matrix.
Notice that, under simple structure, there is an independence assumption, which
leads this structure not realistic for repeated measures data most of time.
Compound symmetric structure specifies repeated measurements on same subject
share same covariance and each has same variance, representing by 𝜎𝐶𝑆,𝑏 2 and 𝜎𝐶𝑆,𝑏 2 +
𝜎𝐶𝑆,𝑤 2 , respectively. Because of this kind of representation, compound symmetric
structure is also called variance components structure. The correlation function
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is𝜎

𝜎𝐶𝑆,𝑏 2

𝐶𝑆,𝑏

2 +𝜎
2
𝐶𝑆,𝑤

. Correlation here is free of time difference and it is nonnegative, in other

words, any pair of measurements on same subjects should have same nonnegative
correlation. In matrix form, it can be shown as
𝐆 = 𝜎𝐶𝑆,𝑏 2 𝑰 𝑎𝑛𝑑 𝑹𝒊𝒋 = 𝜎𝐶𝑆,𝑤 2 𝑰, 𝑜𝑟
𝐆 = 𝟎 𝑎𝑛𝑑 𝑹𝒊𝒋 = 𝜎𝐶𝑆,𝑤 2 𝑰 + 𝜎𝐶𝑆,𝑏 2 𝑱
Depend on certain cases, people can choose why to define their matrices.
Similar to the definition of AR(1) in time series, this covariance structure assumes
all measurements have the same variance and the covariance between measurements on
same subjects has a regressive relation; specifically speaking, covariance decreases with
the increasing of time difference.
𝑐𝑜𝑣(𝑦𝑖𝑗𝑘 , 𝑦𝑖𝑗𝑙 ) = 𝜎𝐴𝑅(1) 2 𝜌𝐴𝑅(1) |𝑘−𝑙| , 𝑎𝑛𝑑
𝐆 = 𝟎 𝑎𝑛𝑑 𝑹𝒊𝒋 = 𝜎𝐴𝑅(1) 2 𝜌𝐴𝑅(1) |𝑘−𝑙|
Consider the second aspect of the covariance structure for repeated measures
design, AR(1) meets the requirement much better than first two, and it, perhaps, is the
most commonly used structure.
The only difference between this structure and last one is variance partitions into
within-subject and between-subjects due to the random effect adding in to subjects. So
the variance and covariance now look as following
𝑣𝑎𝑟(𝑦𝑖𝑗𝑘 ) = 𝜎AR(1)+RE,b 2 + 𝜎AR(1)+RE,w 2 𝑎𝑛𝑑
𝑐𝑜𝑟𝑟AR(1)+RE =

𝜎AR(1)+RE,b 2 + 𝜎AR(1)+RE,w 2 𝜌𝐴𝑅(1)+𝑅𝐸 |𝑘−𝑙|
𝜎AR(1)+RE,b 2 + 𝜎AR(1)+RE,w 2

In terms of matrix, 𝐆 = 𝜎AR(1)+RE,b 2 𝑰 𝑎𝑛𝑑 𝑹𝒊𝒋 = 𝜎𝐴𝑅(1) 2 𝜌𝐴𝑅(1)+𝑅𝐸 |𝑘−𝑙|
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Toeplitz structure, sometimes called ‘banded’, specifies that covariance depends
only on time difference, but not as a mathematical function with a smaller number of
parameters. The correlation function is

𝜎𝑇𝑂𝐸𝑃,|𝑑𝑖𝑓𝑓|
𝜎𝑇𝑂𝐸𝑃 2

and 𝐆 = 𝟎 and R is a matrix with

𝜎𝑇𝑂𝐸𝑃 2 on the main diagonal and 𝜎𝑇𝑂𝐸𝑃,|𝑑𝑖𝑓𝑓| on a sub-diagonal |𝑘 − 𝑙|, where 𝑘 is the
row number and 𝑙 is the column number. (Littell, et al., 2000)
The unstructured structure specifies no patterns generally. It needs a very large
amount of parameter and requires a large data set to make result precisely.
AR (1) and TOEP are both widely used handing covariance structure issues for
repeated measures data. However, they have an outstanding limit; that is, both those
structures make sense when time points (or spaces) are equally spaced.
In reality, time points are not always evenly assigned in experiment. We need
covariance structure for this general case. Ante-dependence model with order 1 can
handle this problem. In this case, R is a matrix with 𝜎𝑘 2 in main diagonal and
𝜎1 𝜎𝑘 ∏𝑘−1
𝑖=1 𝜌𝑖 on off-diagonal, where k is the number of measurements.
There are many other covariance structures useful in unequal spaced cases. The
most common of these are SP (POW) (spatial power law), SP (GAU) (gaussian), and SP
(SPH) (spherical). (Littell, et al. 2000)
For example, SP (POW) provides a generalization of the AR (1) structure for
unequal spaced data. It produces cov(𝑦𝑖𝑗𝑘 − 𝑦𝑖𝑗𝑙 ) = 𝜎𝑆𝑃(𝑃𝑂𝑊) 2 𝜌|𝑘−𝑙| and ρ is an
autoregressive parameter with |𝜌| < 1.
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Section 4.5 Advantages and Disadvantages of Repeated-measures Design
A repeated measures design is using the same participants for all of your
experimental conditions (Field, 2011). This is in contrast to other standard designs. A
benefit of using repeated measures (using the same participants for both manipulations) is
it allows the researcher to exclude the effects of individual differences that could occur if
two different people were used instead (Howitt & Cramer, 2011). Each subject serves as
own control so that between-subject effects get isolated, which makes the analysis focus
on treatment effects more precisely.
Recall what we said in section 1 of this chapter, repeated measures designs ask
fewer subjects than other related independent groups designs; this fact makes repeated
measures designs more efficient and convenient. Apart from all advantages above,
repeated measures design can detect the effects of all independent variable, no matter
they are significant or relatively small, so we can say repeated measures is more sensitive
than other standard designs.
Repeated measures designs also have their limits. Generally, these limits can be
conclude as following three aspects:
1. Carry-over Effect. It happens when a treatment is applied before the effects of
previous one has worn off. So researchers need sufficient long time between
treatments.
2. Latent Effect. If two treatments were relatively related, the later one may
activate the effects of previous treatment. This can mislead the results and
conclusions of experiment.
3. Learning Effect. Since this kind of design use same subject for all conditions
(treatments), subject can improve, or get worse, at each time of measurements,
especially when subjects are people. This effect can change the conclusions
made for treatments.
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Section 4.6 Repeated Measures Designs and Split-plot Designs
In section 4, we notice that the first aspect of covariance structure is the similarity
to the assumption made for measurements on same whole plot in Split-plot design, which
implies Split-plot design and repeated measures design are comparable. The only feature
to make them different is the second aspect of covariance. In repeated measures design,
we take repeated measurements over time for each subject. These subjects can be looked
on as whole plots. So if all these repeated measurements are equally correlated over time,
then time effect is nothing but a sub-plot effect. Actually, this case is following the
Univariate ANOVA approach in Section 4.
The ANOVA table for a split-plot design can be used as an approximation
ANOVA to its related repeated measurement. The thing we need to do is we need to
modify the degrees of freedom of repeated factors and interactions involving them. This
new degree of freedoms are called Conservative degree of freedom. The specific method
is replace the degrees of freedom of repeated factors by 1’s. For instance, consider Table
2 in Chapter 1. If we use it as the approximate ANOVA table for related repeated
measures design. Here βk can be considered as the repeated factor effect for its related
repeated measures design. W can see conservative d.f.’s as what are shown in Table
4.5.1.
And then we can use Conservative d.f. column in Table 4.5.1 to do tests for
effects. If these two designs give different results, modifying degree of freedom, using
REPEATED statement, or testing assumptions can be used to solve some cases, but not
all. This issue is beyond the scope here. However, if repeated measurements are
significant when conservative d.f. are used, conclusions from both designs are sound.
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Table 4.5.1 Approximate ANOVA of repeated measurements analysis
Conservative
Sources
d.f.
d.f.
αi
m-1
m-1
Whole plot

Split plot

θj

n-1

n-1

(αθ)ij

(m-1)(n-1)

(m-1)(n-1)

βk

b-1

1

(αβ)ik

(m-1)(b-1)

m-1

(θβ)jk

(n-1)(b-1)

n-1

(αθβ)ijk

(m-1)(n-1)(b-1)

(m-1)(n-1)

εijk
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CHAPTER 5: SUMMARY

There is no simple answer to say which design fits the experiment best. Based on
different biological requirements, different designs would be chosen. Split-plot design is
convenient in having to grow only a limited number of plants and saves time and funds,
and it can satisfy most research goals. However, repeated-measures design provides
flexibility of component structure, which gives us a chance to taking covariance between
time points into account and supports our cyclic pattern assumption. There must be more
designs can fit the data and experiment better, so the research based on this set of data
will last long.
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GLOSSARY

Analysis of variance (ANOVA): a procedure for constructing statistical tests by
partitioning the total variance into different sources.
Biological replicates: biological samples obtained in replicate form independent
sources representing the same condition.
Decomposition: separation of a complex variance term in an ANOVA model into
its components, which is attributable to all effects and their interactions.
Degree of freedom: the number of levels that can vary freely in a term of an
ANOVA model. It is typically one less than the number of levels in the factor.
Error variation: the variation associated with an estimated quantity. It is the
square of the standard error and in commonly used to assess the accuracy of estimation.
Fixed effect: a term in an ANOVA model for which the levels are going to be
repeated exactly if the experiment is repeated. We are generally interested in the mean
values associated with levels of a fixed effect.
Gene expression profiling: the monitoring of differences in the level of
expression of thousands of individual genes across a series of treatments.
Mixed-model ANOVA: an ANOVA model in which some terms are treated as
random effects and others as fixed effects. In a mixed model there may be multiple
sources of random variation.
Normalization: the process of removing certain systematic biased form
microarray data.
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Null hypothesis: a hypothesis for which the effects of interest are assumed to be
absent. Commonly used as a basis for constructing statistical tests.
Power: the probability that a real effect can be identified by a statistical test. It is
one minus the type II error probability.
P-value: a measure of the evidence against the null hypothesis in a statistical test.
It is the probability of the occurrence of a test statistic equal to, or more extreme than, the
observed value under the assumption that the null hypothesis is true.
Random effect: a term in ANOVA model for which the levels represent a sample
from a population of levels. In a replicated experiment the same values will not repeat.
We are generally interested in the variability associated with a random effect.
Residual: the difference between an observed data value and its expectation as
predicted by a model. It is the lowest-level term in ANOVA model, denoted as 𝑒𝑖 .
Residual sums of squares: the sum of all the residuals squared. It is a measure of
the total discrepancy between a model and the observed data.
Restricted maximum likelihood: a numerical method for estimating variance
components in a mixed ANOVA model.
Significance level: the size of p-value that is regarded as providing sufficient
evidence against a null hypothesis. If the p-value falls below the significance level, the
null hypothesis is rejected.
Technical replicates: multiple RNA samples obtained from the same biological
source.
Type I error: the event of rejecting a null hypothesis when it is true.
Type II error: the event of failing to reject a null hypothesis when it is false.
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APPENDICES

Appendix I Deriving Sum of Squares
Step 1: Decomposition
𝑦𝑖𝑗𝑘 − 𝑦… = (𝑦𝑖.. − 𝑦… ) + (𝑦.𝑗. − 𝑦… ) + (𝑦𝑖𝑗. − 𝑦𝑖.. − 𝑦.𝑗. + 𝑦… ) + (𝑦..𝑘 − 𝑦… )
+ (𝑦𝑖.𝑘 − 𝑦𝑖.. − 𝑦..𝑘 + 𝑦… ) + (𝑦.𝑗𝑘 − 𝑦.𝑗. − 𝑦..𝑘 + 𝑦… ) + (𝑦𝑖𝑗𝑘 − 𝑦𝑖𝑗. − 𝑦𝑖.𝑘
− 𝑦.𝑗𝑘 + 𝑦𝑖.. + 𝑦.𝑗. + 𝑦..𝑘 + 𝑦… )
When doing decomposition for each term in model, we need to check if left and
right sides are equal after cancellation. Left and right sides are equal for our case. At the
same time, left side is the estimate of µ, and portions in right side are estimates for αi , θj ,
(αθ)ij , βk, (αβ)ik , (θβ)jk , (αθβ)ijk, respectively.
Step 2: Adding Summation Symbol for Both Sides
𝑚

𝑛

𝑏

∑ ∑ ∑(𝑦𝑖𝑗𝑘 − 𝑦… )2
𝑖=1 𝑗=1 𝑘=1
𝑚

𝑛

𝑏

= ∑ ∑ ∑[(𝑦𝑖.. − 𝑦… ) + (𝑦.𝑗. − 𝑦… ) + (𝑦𝑖𝑗. − 𝑦𝑖.. − 𝑦.𝑗. + 𝑦… )
𝑖=1 𝑗=1 𝑘=1

+ (𝑦..𝑘 − 𝑦… ) + (𝑦𝑖.𝑘 − 𝑦𝑖.. − 𝑦..𝑘 + 𝑦… ) + (𝑦.𝑗𝑘 − 𝑦.𝑗. − 𝑦..𝑘 + 𝑦… )
+ (𝑦𝑖𝑗𝑘 − 𝑦𝑖𝑗. − 𝑦𝑖.𝑘 − 𝑦.𝑗𝑘 + 𝑦𝑖.. + 𝑦.𝑗. + 𝑦..𝑘 + 𝑦… )]2
Sum of squares on both sides are equal naturally since roots for both sides equals
from step 1.
Step 3: Simplify right side
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𝑚

𝑛

𝑏

∑ ∑ ∑[(𝑦𝑖.. − 𝑦… ) + (𝑦.𝑗. − 𝑦… ) + (𝑦𝑖𝑗. − 𝑦𝑖.. − 𝑦.𝑗. + 𝑦… ) + (𝑦..𝑘 − 𝑦… )
𝑖=1 𝑗=1 𝑘=1

+ (𝑦𝑖.𝑘 − 𝑦𝑖.. − 𝑦..𝑘 + 𝑦… ) + (𝑦.𝑗𝑘 − 𝑦.𝑗. − 𝑦..𝑘 + 𝑦… )
+ (𝑦𝑖𝑗𝑘 − 𝑦𝑖𝑗. − 𝑦𝑖.𝑘 − 𝑦.𝑗𝑘 + 𝑦𝑖.. + 𝑦.𝑗. + 𝑦..𝑘 + 𝑦… )]
𝑚

𝑛

𝑏

𝑚

𝑛

𝑏

𝑚

𝑛

2

𝑏

2

= ∑ ∑ ∑(𝑦𝑖.. − 𝑦… )2 + ∑ ∑ ∑(𝑦.𝑗. − 𝑦… ) + ∑ ∑ ∑(𝑦𝑖𝑗. − 𝑦𝑖.. − 𝑦.𝑗. + 𝑦… )
𝑖=1 𝑗=1 𝑘=1

𝑖=1 𝑗=1 𝑘=1
𝑚

𝑛

2

𝑖=1 𝑗=1 𝑘=1

𝑏

𝑚

𝑛

𝑏

+ ∑ ∑ ∑(𝑦..𝑘 − 𝑦… )2 + ∑ ∑ ∑(𝑦𝑖.𝑘 − 𝑦𝑖.. − 𝑦..𝑘 + 𝑦… )2
𝑖=1 𝑗=1 𝑘=1
𝑚

𝑛

𝑖=1 𝑗=1 𝑘=1

𝑏

+ ∑ ∑ ∑(𝑦.𝑗𝑘 − 𝑦.𝑗. − 𝑦..𝑘 + 𝑦… )

2

𝑖=1 𝑗=1 𝑘=1
𝑚

𝑛

𝑏

+ ∑ ∑ ∑(𝑦𝑖𝑗𝑘 − 𝑦𝑖𝑗. − 𝑦𝑖.𝑘 − 𝑦.𝑗𝑘 + 𝑦𝑖.. + 𝑦.𝑗. + 𝑦..𝑘 + 𝑦… )

2

𝑖=1 𝑗=1 𝑘=1

All interaction terms are equal to zero based on our assumption for model. Taking
first two term of right side in step 1 as an example.
𝑚

𝑛

𝑏

∑ ∑ ∑ ((𝑦𝑖.. − 𝑦… ) + (𝑦.𝑗. − 𝑦… ))

2

𝑖=1 𝑗=1 𝑘=1
𝑚

𝑛

𝑏

𝑚

= ∑ ∑ ∑(𝑦𝑖.. − 𝑦…

)2

𝑛

𝑏

+ ∑ ∑ ∑(𝑦𝑖.. − 𝑦… )(𝑦.𝑗. − 𝑦… )

𝑖=1 𝑗=1 𝑘=1
𝑚

𝑛

𝑖=1 𝑗=1 𝑘=1

𝑏

+ ∑ ∑ ∑(𝑦.𝑗. − 𝑦… )

2

𝑖=1 𝑗=1 𝑘=1
𝑚

𝑛

𝑏

= ∑ ∑ ∑(𝑦𝑖.. − 𝑦…
𝑖=1 𝑗=1 𝑘=1

𝑚

)2

𝑛

𝑏

𝑚

𝑛

𝑏

+ ∑ ∑ ∑(𝛼𝑖 )(𝜃𝑗 ) + ∑ ∑ ∑(𝑦.𝑗. − 𝑦… )
𝑖=1 𝑗=1 𝑘=1
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𝑖=1 𝑗=1 𝑘=1

2

𝑚

𝑛

𝑏

= ∑ ∑ ∑(𝑦𝑖.. − 𝑦… )2 + 𝑏 ∑
𝑖=1 𝑗=1 𝑘=1
𝑚

𝑛

𝑚

𝑚

𝑛

𝑖=1

𝛼𝑖 ∑

𝑏

𝑚

𝑗=1

𝑛

𝑛

𝜃𝑗 + ∑ ∑ ∑(𝑦.𝑗. − 𝑦… )

2

𝑖=1 𝑗=1 𝑘=1

𝑏

= ∑ ∑ ∑(𝑦𝑖.. − 𝑦… )2 + ∑ ∑ ∑(𝑦.𝑗. − 𝑦… )
𝑖=1 𝑗=1 𝑘=1

𝑏

2

𝑖=1 𝑗=1 𝑘=1

𝑚

𝑛

= 𝑛𝑏 ∑(𝑦𝑖.. − 𝑦… )2 + 𝑚𝑏 ∑(𝑦.𝑗. − 𝑦… )2
𝑖=1

𝑗=1

For rest terms on right side, similar way and assumption can be applied to. After
simplification, we can get following result for right side of equation.
Right side
𝑚

𝑛

𝑚

2

𝑛

2

= 𝑛𝑏 ∑(𝑦𝑖.. − 𝑦… ) + 𝑚𝑏 ∑(𝑦.𝑗. − 𝑦… ) + 𝑏 ∑ ∑(𝑦𝑖𝑗. − 𝑦𝑖.. − 𝑦.𝑗. + 𝑦… )2
𝑖=1

𝑗=1

𝑖=1 𝑗=1

𝑏

𝑚

𝑏

2

+ 𝑚𝑛 ∑(𝑦..𝑘 − 𝑦… ) + 𝑛 ∑ ∑(𝑦𝑖.𝑘 − 𝑦𝑖.. − 𝑦..𝑘 + 𝑦… )2
𝑘=1
𝑛

𝑖=1 𝑘=1

𝑏

+ 𝑚 ∑ ∑(𝑦.𝑗𝑘 − 𝑦.𝑗. − 𝑦..𝑘 + 𝑦… )2
𝑗=1 𝑘=1
𝑚

𝑛

𝑏

+ ∑ ∑ ∑(𝑦𝑖𝑗𝑘 − 𝑦𝑖𝑗. − 𝑦𝑖.𝑘 − 𝑦.𝑗𝑘 + 𝑦𝑖.. + 𝑦.𝑗. + 𝑦..𝑘 + 𝑦… )

2

𝑖=1 𝑗=1 𝑘=1

Step 4: Checking Degree of Freedom
Listing out degree of freedom for each corresponding term in the same order as
what step 1 shows. With basic algebra, it is easy to check left and right side have same
degree of freedom
mnb-1 = (m-1) + (n-1) + (m-1) (n-1) + (b-1) + (m-1) (b-1) + (n-1) (b-1) + (m-1) (n-1)
(b-1)
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Then we can figure out formulas for all sum of squares and estimates for each parameter.

Appendix II Method and Rules for EMS Calculation (Taking Model 1 as an
Example)
1. Setting down a table. Marking row headings (Sources) as variable terms in
model and writing down column headings as subscriptions with numbers of
observations. Here, you need to make sure to add F for fixed levels of factor
and R for random levels.
2. Filling the table. For each column, if fixed subscription appears in
corresponding row heading, then writing down 0; otherwise, filling by number
of observations for that fixed subscription. If random subscription shows up in
corresponding row heading, then writing down 1; otherwise, filling by number
of observations for that random subscription. Note that all cells are filled by 1
in error row, anyway.
3.

Calculating degree of freedom for each random variable. Degree of freedom
is, as usual, computed as number of observation for corresponding
subscription subtracting 1, or product of them. Total degree of freedom is N-1,
where N is the production of all numbers of observations.

After first three steps, we can get Appendix IIA for Model 1. Notice that degree
of freedom for random error term is not computable in this case.
4. Calculation EMS. We prefer to take two variable terms, αi, (θβ)jk, in Table A
as examples for explain the abstract calculation procedure. Since αi is a fixed
variable and (θβ)jk is random, we can see the slightly difference between fixed
and random cases.
For αi, we need to list out all variances related to it, firstly. These variance
contains variance of general random error and all variances with subscriptions containing
at least the notation of the variance we concern, so these variances are σε2, σαθ2, and σα2.
No β term is involved since factor B effect (β’s) haven’t added in yet, in this experiment.
Now, we add coefficients for each term. Coefficients for σε2 are always 1 for any term. To
find coefficient for σαθ2, we can cover up i and j columns in FRF sector in Table A, we
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get b, which is the coefficient for σαθ2. Similar procedure can be applied to find the
coefficient for σα2 by covering up i column, and nb is the coefficient for σα2. Adding them
together, we get σε2 + bσαθ2 + nbσα2. (A tip here is that it would benefit later by writing
σε2 as the first term and the term using symbol representing corresponding effect as the
last one.)

Appendix IIA Degree of freedom for terms in Model 1
m
F
Sources
d.f.
i
αi
m-1
0

n
R
j
n

b
F
k
b

θj

n-1

m

1

b

(αθ)ij

(m-1)(n-1)

0

1

b

βk

b-1

0

n

0

(αβ)ik

(m-1)(b-1)

0

n

0

(θβ)jk

(n-1)(b-1)

0

1

0

(αθβ)ijk

(m-1)(n-1)(b-1)

0

1

0

1

1

1

εijk
Total

mnb-1

Rules start to apply to adjust terms.
1. First and last terms are always remaining.
2. For middle variance component of EMS, covering up the symbol representing
corresponding effect in subscription, α here. If remaining subscription(s) is fixed,
then dropping out this variance term; otherwise, keeping it. Here, remaining
subscription is θ, which is random effect, so we keep this term.
Then we get EMS (αi) = σε2 + bσαθ2 + nbσα2.
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For (θβ)jk, related variances are σε2, σαθβ2, σθβ2, and coefficients are 1, 1, and m,
respectively. After apply rule 1 and 2, we get EMS ((θβ)jk) = σε2 + mσθβ2. Now rule 3
need to be introduced.
3. If the effect is random, then EMS keeps the same as what we have gotten. If it is
fixed, we have to replace the variance component of that fixed effect by Sum of
its squares dividing its degree of freedom.
So, EMS (αi) turns to be σε2 + bσαθ2 + nb

∑𝑖 𝛼𝑖 2
𝑚−1

. However, EMS ((θβ)jk) keeps the

same. Together with all other effect terms, we can get Appendix IIB.

Appendix IIB EMS for all terms in model 1
Sources
EMS
αi

σε2 + bσαθ2 + nb

θj

σε2 +

(αθ)ij
βk

mbσθ

∑𝑖 𝛼𝑖 2
𝑚−1

2

σε2 + bσαθ2
σε2 + σαθβ2 + mσθβ2 + mn
∑ ∑ (𝛼𝛽)

∑𝑘 𝛽𝑘 2

(αβ)ik

𝑖 𝑗
𝑖𝑗
σε2 + σαθβ2 + n (𝑚−1)(𝑏−1)

(θβ)jk

σε2 + mσθβ2

(αθβ)ijk

σε2 + σαθβ2

εijk

𝑏−1

2

σε2

Appendix III Matrix Forms for Models

Matrix Form for General Linear Models. Suppose n data 𝑦1 , … , 𝑦𝑛 are observed and
explained by p explanatory variables with n values for each, 𝑥11 , … , 𝑥1𝑝 , … , 𝑥𝑛1 , … , 𝑥𝑛𝑝 .
The model for it is
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𝑦𝑖 = 𝑥𝑖1 𝛽1 + ⋯ + 𝑥𝑖𝑝 𝛽𝑝 + 𝑒𝑖
Here β’s are unknown fixed effects parameters and 𝑒𝑖 ′𝑠 are i.i.d.
𝑁(0, 𝜎 2 )distributed random variables/ errors. However, we need to write n equations to
represent all observations. In order to make the process simpler, we can use a single
equation by using matrix notations.
𝐘 = 𝐗𝛃 + 𝐞
where
𝑦1
Y represents the vector of all response variables, and 𝐘 = [ ⋮ ];
𝑦𝑛
𝑥11
X is the known matrix of all explanatory variables, and X is defined as [ ⋮
𝑥𝑛1

… 𝑥1𝑝
⋱
⋮ ];
… 𝑥𝑛𝑝

𝛽1
β is the unknown fixed effects parameter vector, and 𝛃 = [ ⋮ ]; and
𝛽𝑛
𝑒1
e is the random error vector with 𝐞 = [ ⋮ ] and e follows 𝑁(𝟎, 𝑽) where 𝑽 = 𝜎 2 𝑰.
𝑒𝑛

Matrix Form for General Linear Mixed Models
For mixed model, both fixed and random effects are involved, such as repeatedmeasures designs. The random effects would allow elements of 𝐘 to be correlated. There
are two approaches to modify general linear model.
First, we can change the assumptions made for random error matrix e
follows 𝑁(𝟎, 𝑹). In this case, matrix e is called as covariance matrix. Notice that
elements in e are not i.i.d. any longer.
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Second, we can add random effects and coefficients in model. Based on general
linear model, we can add Zu terms, where Z matrix is a conditional model and u
follows 𝑁(𝟎, 𝑮). At the same time, e follows 𝑁(𝟎, 𝑹). Models without a Z matrix that
capture complex covariance structure directly through the variance matrix of the errors e
are called marginal models (Littell 2007). In summary, the second approach concludes as
following
𝐘 = 𝐗𝛃 + 𝐙𝐮 + 𝐞
u follows 𝑁(𝟎, 𝑮)
e follows 𝑁(𝟎, 𝑹)
cov[𝐮, 𝐞] = 𝟎
It’s important to understand that assumption cov[𝐮, 𝐞] = 𝟎 is the key feature to
avoid parameter confounding. To be specific, 𝐘, 𝐗, 𝛃 denote the vector of response
variables, the known matrix of all explanatory variables, and the unknown fixed effects
parameter vector, respectively. New term Z is a matrix filled with 1’s and 0’s depending
on specific model you use. Vector u contains all random effects, so it is not parameter
since they are not fixed.
The conditional distribution of 𝐘|𝐮 and the marginal distribution of 𝐘 are
𝐘|𝐮 follows 𝑁(𝑿𝜷 + 𝒁𝒖, 𝑹)
𝐘 follows 𝑁(𝑿𝜷, 𝑽)
𝐕 = 𝒗𝒂𝒓(𝒀) = 𝒁𝑮𝒁′ + 𝑹

Appendix IV Related SAS Codes
proc import out=signals datafile='C:\Users\yxz195\Desktop\signals.xlsx'
DBMS=XLSX REPLACE;
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SHEET="Sheet2";
GETNAMES=YES;
RUN;
proc transpose data=signals
out=signals_trans;
by ID; /*NOTICE:in order to make SAS recognize ID is sorted with ascending order,
ID's should be labeled as GENE00001--GENE16436*/
VAR _1-_72;
run;
data Reduced_names(drop=_NAME_ _LABEL_ );
set signals_trans;
run;
data Signal (rename=(COL1=Signals));
set Reduced_names;
run;
/* proc print data=Signal (OBS=100); run; */
proc import out=Design_matrix datafile='C:\Users\yxz195\Desktop\design.txt'
DBMS=dlm REPLACE;
delimiter='09'x; /*read space-delimited text file into sas*/
GETNAMES=no;
RUN;
data Design (rename=(VAR1=SPE VAR2=TR VAR3=REP VAR4=T));
set Design_matrix;
RUN;
/* PROC PRINT DATA=Design (OBS=200); RUN; */
data Thesis;
set Design ;
set Signal;
run;
/* Proc print data= Thesis (OBS=500); run; */
data NormData; /*normalized data to make them ready to be analyzed*/
set Thesis;
Y=log2(Signals+1); /*not log2(Signals) since there are some signals are 0 in this
dataset*/
run;
/* Proc print data=NormData (OBS=720); RUN; */
/* SPLIT-PLOT DESIGN-GENERAL*/
Proc glm data=NormData;
class ID SPE TR T REP;
model Y = SPE TR SPE*TR T SPE*T T*TR REP(SPE*TR*T)/SS3;
test h=TR E=SPE*TR;
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random SPE*TR REP(SPE*TR*T)/test;
RUN;
Proc mixed data=NormData method=ml;
class ID SPE TR T REP;
model Y = SPE TR SPE*TR T SPE*T T*TR;
random SPE*TR;
RUN;
These two small programs produce same F-ratios.*/
/* Gene-Specific Significant Models */
proc sort data=NormData;
by ID SPE TR T REP;
RUN;
/*Proc print data=NormData (OBS=720); RUN;*/
/*title 'Scatterplot - Two Variables';
proc gplot data= NormData(N=72);
plot Y*T;
RUN;*/
proc import out=genes datafile='C:\Users\yxz195\Desktop\GENES.xlsx'
DBMS=XLSX REPLACE;
SHEET="Sheet1";
GETNAMES=YES;
RUN;
proc print data= gene1;
run;
ods graphics on;
title 'Genes Data';
proc corr data=gene1 nomiss plots=matrix(histogram);
var T0 T4 T8 T12 T24 T48;
run;
ods graphics off;
/*ods exclude all;
ods noresults;
proc mixed data = NormData;
by ID;
class ID SPE TR T REP;
model Y=SPE TR SPE*TR T SPE*T T*TR SPE*TR*T/ outp= NormData1;
random REP(SPE*TR*T);
lsmeans SPE TR SPE*TR T SPE*T T*TR SPE*TR*T/diff;
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ods output covparms=COVparms tests3=Tests3 lsmeans=lsms diffs=Diffs;
run;
ods exclude none;
ods results;
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